Since the 1990s, there has been a rise in the availability and recreational use of a herbal plant called Salvia divinorum. Numerous internet websites have advertised it for sale as a legal herbal alternative to illegal hallucinogens. Initial data surveying use has indicated many young adults are obtaining and using this herb for its psychoactive properties. Reported methods of ingestion for the plant include chewing, and smoking leaves or fortified extracts. Subjective effects of the plant include, affect changes, psychedelic-like changes in perception, and even loss of consciousness. Although the pharmacological properties and possible antidepressant effects have been studied in recent years, little information is known about potential negative impact resulting from recreational use, and scant information about Salvia divinorum currently exists in the psychological and substance abuse literature. While Salvia divinorum appears to be a substance with some therapeutic potential, it also poses some significant dangers as a substance of varying legal status with a potential for abuse.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Baggott, M. J., Erowid, E., Erowid, F., & Mendelson, J. E. (2004). Use of salvia divinorum, an unscheduled hallucinogenic plant: A web-based survey of 500 users. Clinical Pharmacology and Therapeutics 75, 72.
Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., et al. (2004). Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum, is a highly efficacious kappa opioid receptor agonist: Structural and functional considerations. The Journal of Pharmacology and Experimental Therapeutics, 308(3), 1197–1203.
Devine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. The Journal of Pharmacology and Experimental Therapeutics, 266, 1236–1246.
Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. The Proceedings of the National Academy of Sciences of the USA, 85, 5274–5278.
Donzanti, B. A., Althaus, J. S., Payson, M. M., & Von Voigtlander, P. F. (1992). Kappa agonist-induced reduction in dopamine release: Site of action and tolerance. Research Communications in Chemical Pathology and Pharmacology, 78, 193–210.
Drug Enforcement Administration. (2007). List of drugs and chemicals of concern. Internet website: http://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/salvia_d.htm.
Epling, C., & Játiva-M, C. D. (1962). A new species of salvia from Mexico. Botanical Museum. Leaflets Harvard University, 20, 75–76.
Glick, S. D., Maisonneuve, I. M., Raucci, J., & Archer S. (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research, 681, 147–152.
González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157–162.
Haynes, K. R. (2001). Antidepressant effects of the herb salvia divinorum: A case report. Journal of Clinical Psychopharmacology, 21(6), 634–635.
Kuzmin, A. V., Semenova, S., Gerrits, M., Zvartau, E. E., & Van Ree, J. M. (1997). K-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naïve rats and mice. European Journal of Pharmacology, 321, 265–271.
Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage salvia divinorum. Life Sciences, 78(5), 527–531.
Rey, J, & Tennant, C. (2002). Cannabis and mental health. British Medical Journal, 325, 1183–1184.
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman R. B. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences of the USA, 99(18), 11934–11939.
Schaper D. (2006). National Public Radio: Legal, herbal hallucinogenic draws teens, critics. Radio broadcast Washington, DC: NPR.
Schenk, S., Partridge, B., & Shippenberg, T. S. (1999). U69593, a kappaopioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology, 144, 339–346.
Sheffler, D. J., & Roth, B. L. (2003). Salvinorin A: The ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor. Trends in Pharmacological Sciences, 24(3), 107–109.
Siebert, D. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43, 53–56.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992). Opposing tonically active endogeneous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the USA, 89, 2046–2050.
Ukai, M., Suzuki, M., & Mamiya, T. (2002). Effects of U-50, 488H, a kappa opioid receptor agonist, on the learned helplessness model of depression in mice. Journal of Neural Transmission, 109, 1221–1225.
Valdés, L. J. III (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26, 277–283.
Valdes, L. J. III, Diaz, J., & Paul, A. G. (1983). Ethnopharmacology of ska maria pastora (Salvia divinorum, Epling and Játiva-M.). Journal of Ethnopharmacology, 7, 287–312.
Valdes, L. J. III, Butler, W. B., Hatfield, G. M., Paul, A. G., & Koreeda M. (1984). Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, salvia divinorum. Journal of Organic Chemistry, 49, 4716–4720.
Walsh, S. K., Geter-Douglas, B., Strain, E. C., Bigelow, G. E. (2001). Enadoline and butorphanol: Evaluation of k-agonist on cocaine pharmacodynamics and cocaine self-administration in humans. Pharmacology, 299, 147–158.
Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets Harvard University, 20, 77–84.
Wasson, R. G. (1963). Notes on the present status of ololiuhqui and the other hallucinogens of Mexico. Botanical Museum Leaflets Harvard University, 20, 161–193.
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005). Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: Agonist actions at kappa opioid receptors. Psychopharmacology, 179, 551–558.
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004). Effect of the k- opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology, 173, 146–152.
About this article
Cite this article
Appel, J., Kim-Appel, D. The Rise of a New Psychoactive Agent: Salvia divinorum. Int J Ment Health Addiction 5, 248–253 (2007). https://doi.org/10.1007/s11469-007-9086-4
- Salvia divinorum
- Drugs of abuse
- Recreational drugs
- Kappa-opioid receptor
- Herbal drugs